These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 8393143)
1. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V; Samuels HH Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143 [TBL] [Abstract][Full Text] [Related]
2. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079 [TBL] [Abstract][Full Text] [Related]
3. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Au-Fliegner M; Helmer E; Casanova J; Raaka BM; Samuels HH Mol Cell Biol; 1993 Sep; 13(9):5725-37. PubMed ID: 8395010 [TBL] [Abstract][Full Text] [Related]
4. Interactions among receptors, thyroid hormone response elements, and ligands in the regulation of the rat uncoupling protein gene expression by thyroid hormone. Rabelo R; Reyes C; Schifman A; Silva JE Endocrinology; 1996 Aug; 137(8):3478-87. PubMed ID: 8754777 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
7. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. Xu J; Thompson KL; Shephard LB; Hudson LG; Gill GN J Biol Chem; 1993 Jul; 268(21):16065-73. PubMed ID: 8393457 [TBL] [Abstract][Full Text] [Related]
8. A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites. Rahman A; Esmaili A; Saatcioglu F J Biol Chem; 1995 Dec; 270(52):31059-64. PubMed ID: 8537364 [TBL] [Abstract][Full Text] [Related]
9. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080 [TBL] [Abstract][Full Text] [Related]
10. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B; De Luca P; Hagen G; Suske G; Lania L Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480 [TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism. Maciaszek JW; Talmage DA; Viglianti GA J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995 [TBL] [Abstract][Full Text] [Related]
13. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors. Williams GR; Harney JW; Moore DD; Larsen PR; Brent GA Mol Endocrinol; 1992 Oct; 6(10):1527-37. PubMed ID: 1333048 [TBL] [Abstract][Full Text] [Related]
14. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. Chang LJ; McNulty E; Martin M J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat. Desai-Yajnik V; Samuels HH Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737 [No Abstract] [Full Text] [Related]
17. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829 [TBL] [Abstract][Full Text] [Related]
18. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner. Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231 [TBL] [Abstract][Full Text] [Related]
20. A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Hadzic E; Desai-Yajnik V; Helmer E; Guo S; Wu S; Koudinova N; Casanova J; Raaka BM; Samuels HH Mol Cell Biol; 1995 Aug; 15(8):4507-17. PubMed ID: 7623841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]